Landos Biopharma: Q3 Earnings Insights

Landos Biopharma LABP reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Landos Biopharma missed estimated earnings by 6.82%, reporting an EPS of $-0.94 versus an estimate of $-0.88.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.47 which was followed by a 1.22% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Landos Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!